BNP Paribas Financial Markets
EXAS

BNP Paribas Financial Markets’s Exact Sciences EXAS Stock Holding History

BNP Paribas Financial Markets’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-345,249
Closed -$35.1M – 5915
2025
Q4 		$35.1M Buy
345,249
+145,075
+72% +$11.7M 0.02% 867
2025
Q3 		$11M Sell
200,174
-210,304
-51% -$10.5M 0.01% 1481
2025
Q2 		$21.8M Sell
410,478
-138,525
-25% -$7.04M 0.01% 995
2025
Q1 		$23.8M Buy
549,003
+338,006
+160% +$17.1M 0.01% 956
2024
Q4 		$11.9M Buy
210,997
+70,140
+50% +$4.36M 0.01% 1256
2024
Q3 		$9.6M Buy
140,857
+29,493
+26% +$1.66M 0.01% 1190
2024
Q2 		$4.71M Buy
111,364
+5,499
+5% +$303K ﹤0.01% 1443
2024
Q1 		$7.31M Buy
105,865
+2,585
+3% +$164K 0.01% 1220
2023
Q4 		$7.64M Buy
103,280
+6,810
+7% +$446K 0.01% 1172
2023
Q3 		$6.58M Sell
96,470
-3,489
-3% -$296K 0.01% 1097
2023
Q2 		$9.39M Sell
99,959
-355,673
-78% -$27.7M 0.01% 939
2023
Q1 		$30.9M Buy
455,632
+66,875
+17% +$4.3M 0.04% 436
2022
Q4 		$19.2M Buy
+388,757
New +$15.9M 0.03% 677
2022
Q3 		– Sell
-321,827
Closed -$12.7M – 4811
2022
Q2 		$12.7M Buy
321,827
+109,255
+51% +$5.84M 0.02% 788
2022
Q1 		$14.9M Sell
212,572
-20,540
-9% -$1.5M 0.02% 732
2021
Q4 		$18.1M Buy
233,112
+55,357
+31% +$4.89M 0.03% 681
2021
Q3 		$17M Buy
177,755
+1,712
+1% +$181K 0.02% 683
2021
Q2 		$21.9M Buy
176,043
+93,822
+114% +$11.2M 0.03% 614
2021
Q1 		$10.8M Buy
82,221
+21,502
+35% +$2.94M 0.02% 781
2020
Q4 		$8.04M Buy
60,719
+1,890
+3% +$229K 0.02% 898
2020
Q3 		$6M Sell
58,829
-11,826
-17% -$1.02M 0.01% 996
2020
Q2 		$6.14M Sell
70,655
-15,872
-18% -$1.27M 0.01% 954
2020
Q1 		$5.02M Sell
86,527
-164,005
-65% -$13.3M 0.01% 982
2019
Q4 		$23.2M Buy
250,532
+206,637
+471% +$18.2M 0.04% 452
2019
Q3 		$3.97M Sell
43,895
-15,861
-27% -$1.81M 0.01% 1170
2019
Q2 		$7.05M Buy
59,756
+37,031
+163% +$3.73M 0.01% 884
2019
Q1 		$1.97M Buy
22,725
+19,567
+620% +$1.67M ﹤0.01% 1399
2018
Q4 		$199K Buy
3,158
+73
+2% +$5.01K ﹤0.01% 2090
2018
Q3 		$243K Buy
3,085
+473
+18% +$30.8K ﹤0.01% 2323
2018
Q2 		$156K Sell
2,612
-22,464
-90% -$1.21M ﹤0.01% 2565
2018
Q1 		$1.01M Buy
25,076
+472
+2% +$23K ﹤0.01% 1725
2017
Q4 		$1.29M Buy
24,604
+10,452
+74% +$558K ﹤0.01% 1785
2017
Q3 		$667K Buy
14,152
+492
+4% +$19.8K ﹤0.01% 1829
2017
Q2 		$483K Buy
13,660
+11,377
+498% +$351K ﹤0.01% 1924
2017
Q1 		$53.9K Sell
2,283
-1,316
-37% -$26.1K ﹤0.01% 2712
2016
Q4 		$48.1K Sell
3,599
-5,293
-60% -$85.5K ﹤0.01% 2852
2016
Q3 		$165K Buy
8,892
+4,982
+127% +$87.8K ﹤0.01% 1851
2016
Q2 		$47.9K Buy
3,910
+3,204
+454% +$24.1K ﹤0.01% 2316
2016
Q1 		$4.76K Sell
706
-24,058
-97% -$154K ﹤0.01% 2287
2015
Q4 		$229K Sell
24,764
-25,206
-50% -$234K ﹤0.01% 1847
2015
Q3 		$899K Buy
49,970
+9,952
+25% +$229K ﹤0.01% 1084
2015
Q2 		$1.19M Buy
40,018
+36,773
+1,133% +$924K ﹤0.01% 1073
2015
Q1 		$71.5K Buy
3,245
+1,772
+120% +$45K ﹤0.01% 1826
2014
Q4 		$40.4K Sell
1,473
-803,698
-100% -$19.6M ﹤0.01% 1720
2014
Q3 		$15.6M Sell
805,171
-94,846
-11% -$1.74M 0.01% 385
2014
Q2 		$15.3M Buy
900,017
+900,007
+9,000,070% +$12.4M 0.01% 313
2014
Q1 		$120 Sell
10
-903
-99% -$12.2K ﹤0.01% 3283
2013
Q4 		$10.7K Sell
913
-17,905
-95% -$205K ﹤0.01% 2602
2013
Q3 		$222K Sell
18,818
-3,557
-16% -$45.6K ﹤0.01% 2167
2013
Q2 		$311K Buy
+22,375
New +$243K ﹤0.01% 1957

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

BNP Paribas Financial Markets's EXAS Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 345,249 shares — an estimated $35.1M sold.

BNP Paribas Financial Markets first reported a position in EXAS in Q2 2013 and held it in 50 quarters. The position peaked at $35.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 345,249 Exact Sciences shares in Q1 2026, an estimated $35.1M.
  • BNP Paribas Financial Markets first reported a position in Exact Sciences in Q2 2013 and held it in 50 quarters.
  • BNP Paribas Financial Markets's Exact Sciences position peaked at $35.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.